Schedule 13G ownership disclosure

Mirum Pharmaceuticals Inc

Security class unavailable · CUSIP: 604749101

Event date: 2021-10-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
530,562
Percent of class
1.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001395064-21-000213
Form type
SC 13G/A
Filer
Mirum Pharmaceuticals, Inc.
CIK
CIK 1759425
Filed
Oct 25, 2021
Reporting period
Oct 19, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub